Mirion Technologies (MIR) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Mirion Technologies

NYSE•Industrials•Specialty Industrial Machinery

$15.98+0.14(0.01%)Market closed

Market Cap

$3.87B

P/E

158.1x

P/S

3.8x

P/B

2.1x

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company also offers include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

How this company scores

ExcellentMetricSide Score: 85/100

Strongest: Cash & Earnings Quality (25/25); weakest: Profitability (14/25).

Profitability14/25

Growth22/25

Balance Sheet & Red Flags24/25

Cash & Earnings Quality25/25

Strengths

Growing revenueRising free cash flowRising earningsLow leverage

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 158.1x5y range 31.6x – 484.5x

Currently near its 7-quarter median.

P/S · 3.8x5y range 2.4x – 11.5x

Currently near its 17-quarter median.

P/B · 2.1x5y range 1.0x – 3.3x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $3.87B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.02B
Q. Revenue: $266.80M
TTM EBITDA: $204.60M
TTM Op. Income: $54.50M
Q. Op. Income: $17.90M
TTM Net Income: $24.50M
Q. Net Income: $7.70M
EPS: $0.03
Shares Out.: $244.56M

$1.02B in TTM revenue grew 15.7% YoY, reaching $266.80M last quarter. TTM EBITDA of $204.60M and TTM operating income of $54.50M show growth is flowing through to the bottom line. TTM net income of $24.50M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 49.9%
EBITDA Margin: 21.3%
Op. Margin: 6.7%
Net Margin: 2.9%

Op. margin of 6.7% is up 2.3% YoY — cost efficiency is improving. Net margin at 2.9% and gross margin of 49.9% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 51% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 158.1x
P/S Ratio: 3.8x
P/B Ratio: 2.1x

At 158.1x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 3.8x and P/B of 2.1x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 5 quarters, P/E has fallen for 2 consecutive quarters — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $3.52B
Cash: $418.70M
Long-Term Debt: $443.70M
Book Value: $1.83B
D/E Ratio: 0.2
Debt/EBITDA: 7.8

With $3.52B in assets and $443.70M in long-term debt, D/E is 0.2and book value is $1.83B — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has risen for 2 consecutive quarters — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $58.50M
TTM Free Cash Flow: $133.70M
FCF Margin: 13.0%
FCF / Net Income: 5.5

TTM FCF of $133.70M on $58.50M in operating cash flow. The FCF / Net Income ratio of 5.5x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 60% — an improving trend.